Prof. Dr. SAFİYE AKTAŞ

Yayın Ağı

Makaleler 263

1. Tri-Modal Anticancer Therapy via Mo2C-MXene-Based Hybrid Nanostructures: A Synergistic Strategy Against Triple-Negative Breast Cancer

Tunçel A., Ozel D., Kaya G., Sert B., YILMAZ O., AKTAŞ S., et al.

ACS Applied Materials and Interfaces , cilt.17, sa.46, ss.63069-63088, 2025 (SCI-Expanded, Scopus)

2. Targeted Therapy for Glioblastoma: Synergistic Effects of GO/C-TMZ,@, PmAb and Magnetic Hyperthermia

Ozel D., Tunçel A., Kaya G., Sert B., YILMAZ O., AKTAŞ S., et al.

ACS Applied Bio Materials , cilt.8, sa.9, ss.7855-7876, 2025 (ESCI)

3. Pediatric and young adult ovarian masses: clinical approach, diagnostic evaluation, and management

Bayramoğlu Z., Timur B., Kızmazoğlu D., Timur H. T., Ulusoy O., Aktaş S., et al.

FRONTIERS IN PEDIATRICS , cilt.13, sa.1, ss.1-6, 2025 (SCI-Expanded)

4. Determination of a New Biomarker at the Level of Gene Alteration in Cisplatin Ototoxicity

KIZMAZOĞLU D., Erol A., Aktaş T. Ç., OLGUN Y., Demir A. B., ALTUN Z. S., et al.

International Journal of Molecular Sciences , cilt.26, sa.18, 2025 (SCI-Expanded)

5. Potential Therapeutic Synergy of Thymoquinone and Nivolumab in Experimental Models of Renal Cancer

Dirican A., Gökbayrak Ö., Erol A., Aktaş T., Kolatan E., Serinan E., et al.

İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi , cilt.10, sa.3, ss.1-9, 2025 (Hakemli Dergi)

6. Anti-Cancer treatments affecting PI3K/Akt/Mtor and Ras/MAPK pathways in neuroblastoma

Gökbayrak Ö. E., Aktaş S., Erol A., Altun Z. S., Olgun N.

Developments and Experiments in Health and Medicine , cilt.39, sa.3, ss.153-163, 2025 (Hakemli Dergi)

7. The Effect of MicroRNA 21 and MicroRNA 200b Expression on Carcinogenesis in Endometriosis-Associated Ovarian Cancers and Relationship with Clinicopathological Parameters

Talu E. C. K., Ulukus E. C., ÇAKIR Y., GÜRAY DURAK M., BAYRAMOĞLU Z., TİMUR H. T., et al.

MEDICINA-LITHUANIA , cilt.61, sa.6, 2025 (SCI-Expanded)

8. Potential diagnostic and prognostic biomarkers of pediatric Burkitt lymphoma identified through miRNA expression profiling.

Küçük C., Sönmez E. E., Hatipoğlu T., Yuan H., Hu X., Ceylan A., et al.

Pediatric research , cilt.97, sa.6, ss.2114-2125, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

9. RHOB Ekspresyonun Nöroblastomda Moleküler Risk Sınıfları ve Prognoz ile İlişkisinin Değerlendirilmesi

Baran B., Sanlav G., Kum Özşengezer S., Kızmazoğlu D., Aktaş S., Altun Z. S., et al.

Uludağ Üniversitesi Tıp Fakültesi Dergisi , cilt.50, sa.3, ss.449-455, 2025 (Hakemli Dergi)

10. Inflammation-Associated Long Non-Coding RNAs (lncRNAs) in Chronic Viral Hepatitis-Associated Hepatocellular Carcinoma

Pehlivanoglu B., Aysal A., Agalar C., Egeli T., Ozbilgin M., Unek T., et al.

TURKISH JOURNAL OF PATHOLOGY , cilt.41, sa.1, ss.1-8, 2025 (ESCI) Sürdürülebilir Kalkınma

11. The Effect of Adipocyte-Derived Stem Cell Media on Stem Cell Markers in Neuroblastoma Cells

Ozsengezer S. K., ALTUN Z. S., Serinan E., AKTAŞ S., Ercetin P., Olgun N.

JOURNAL OF BEHCET UZ CHILDRENS HOSPITAL , cilt.15, sa.1, ss.24-34, 2025 (ESCI)

12. Morphomolecular Correlation and Clinicopathologic Analysis in Endometrial Carcinoma

BÜLBÜL G., Aktaş T. Ç., Ağalar A. A., AKTAŞ S., KURT S., Saatli B., et al.

International Journal of Gynecological Pathology , cilt.43, sa.6, ss.535-556, 2024 (SCI-Expanded)

13. Thiol-Disulfide Homeostasis in Noise-Induced Hearing Loss in Rats

Aydın E., Mungan Durankaya S., Yılmaz O., Kırkım G., Aktaş S., Neşelioğlu S., et al.

Journal of International Advanced Otology , cilt.20, sa.6, ss.466-471, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

14. Low Expression of CASP8 Could be a Prognostic Biomarker in Neuroblastoma Patients

Altun Z. S., Ceyhan M., Yuan H., Kızmazoğlu D., Aktaş S., Olgun N.

JOURNAL OF CHILD NEUROLOGY , cilt.39, sa.11-12, ss.386-394, 2024 (SCI-Expanded, Scopus)

15. Bone Cancer Metastatic Model on Pla Scaffold with Breast Cancer Cell Lines

Bekcioğlu Ö., Aydın M., Hüsemoğlu B., Aktaş S., Havıtcıoğlu H., Olgun H. N.

Turk J Hip Surg , cilt.4, sa.3, ss.209-213, 2024 (Hakemli Dergi)

16. Investigation of YAP-1, OTX-2, and nestin protein expressions in neuroblastoma: a preliminary study.

Kum Özşengezer S., ALTUN Z. S., Sanlav G., BARAN B., KIZMAZOĞLU D., AKTAŞ S., et al.

Annals of clinical and translational neurology , cilt.11, sa.8, ss.2153-2165, 2024 (SCI-Expanded)

17. Fucoidan Inhibits Prostate Cancer Growth Through Modulation of Different Cell Deaths

Tutuncu M., Sanlav G., AKTAŞ S., YILMAZ O., ALTUN Z. S.

NIGERIAN JOURNAL OF CLINICAL PRACTICE , cilt.27, sa.7, ss.827-836, 2024 (SCI-Expanded)

18. Molecular pathways of common breast cancer metastases and the distinguishing features of triple-negative breast cancer

Bozkurt K. K., Aktaş S., Güray Durak M.

Archives of Current Medical Research , cilt.5, sa.2, ss.50-55, 2024 (Hakemli Dergi)

19. The Impact of Oleuropein on Cisplatin-Induced Toxicity in Cochlear Cells in Relation to the Expression of Deoxyribonucleic Acid Damage-Associated Genes.

OLGUN Y., ALTUN Z. S., Tütüncü M., Özşengezer S. K., AKTAŞ S., GÜNERİ E. A.

The journal of international advanced otology , cilt.20, sa.3, ss.189-195, 2024 (SCI-Expanded, Scopus)

20. lncRNA XIST Interacts with Regulatory T Cells within the Tumor Microenvironment in Chronic Hepatitis B-Associated Hepatocellular Carcinoma

Pehlivanoglu B., Aysal A., Agalar C., Egeli T., Ozbilgin M., Unek T., et al.

TURKISH JOURNAL OF PATHOLOGY , cilt.40, sa.2, ss.101-108, 2024 (ESCI)

21. The prognostic significance of PD-1 and its ligands in non-small cell lung cancer.

Usluer O., Gökbayrak Ö. E., Erol A., Aktaş T. Ç., Batıhan G., Kaya Ş. Ö., et al.

Turk gogus kalp damar cerrahisi dergisi , cilt.32, sa.1, ss.84-92, 2024 (SCI-Expanded)

22. Association Angiotensin Converting Enzyme-2 with Lung Cancer

Ertuğrul A. V., Ömeroğlu Şimşek G., Aktaş T. Ç., Keskinkılıç M., Aktaş S.

İzmir Kâtip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi , cilt.9, sa.1, ss.81-86, 2024 (Hakemli Dergi)

23. COMPARISON OF EFFICACY OF HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPEUTICS MITOMYCIN C VERSUS OXALIPLATIN IN EXPERIMENTAL COLORECTAL PERITONEAL METASTASIS MODEL

MANOĞLU B., CANDA A. E., YAVUZŞEN T., AKTAŞ S., ALTUN Z., YILMAZ O., et al.

JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES , cilt.8, ss.181-191, 2024 (ESCI, TRDizin)

24. S-100 and MATH-1 Protein Expressions Can Be Useful for the Prediction of Clinical Outcome in Neuroblastoma Patients.

Sanlav G., Baran B., Kum Özşengezer S., Kizmazoğlu D., Altun Z. S., Aktaş S., et al.

Journal of pediatric hematology/oncology , cilt.46, sa.1, ss.21-28, 2024 (SCI-Expanded, Scopus)

25. THE INVESTIGATION OF PROTECTIVE ROLE OF ACETYL L-CARNITINE ON CISPLATIN MYELOSUPPRESSION IN EXPERIMENTAL ANIMAL MODEL

KIZMAZOGLU D., İNCE D., AKTAŞ S., ALTUN Z. S., YILMAZ O., OLGUN H. N., et al.

IZTU Journal of Medical and Health Sciences , cilt.2, sa.2, ss.53-62, 2024 (Hakemli Dergi)

26. MORPHOMOLECULAR CORRELATION AND CLINICOPATHOLOGICAL ANALYSIS IN ENDOMETRIALCARCINOMA

Bülbül G., Aktaş T. Ç., Aysal Ağalar A., Aktaş S., Kurt S., Saatlı H. B., et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY , cilt.22, sa.5294R1, ss.1-8, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

27. Botryoid rhabdomyosarcoma or parasites: transnasal choledoscopy as a diagnostic tool

Seker G., Akarsu M., Guler Y., Aydin Ö. G., AKTAŞ S., YÜCEL ÖZTÜRK Y.

ENDOSCOPY , cilt.55, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

28. BRAF MUTATION EXISTING WITH RAS MUTATIONS IN NEUROBLASTOMA

Aktaş T. Ç., Erol A., Kızmazoğlu D., Aktaş S., Olgun H. N.

Turk J Biochem 2023 , cilt.48, sa.s2, ss.63-65, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

29. The Logarithmic Ratio of Positive Lymph Nodes Predicts Survival in Patients with Larynx Squamous Cell Carcinoma

Eliyatkin N. O., BAYRAK A. F., Islek A., Kilic H. S., AKTAŞ S.

CYPRUS JOURNAL OF MEDICAL SCIENCES , cilt.8, sa.6, ss.435-440, 2023 (ESCI) Sürdürülebilir Kalkınma

30. Identification of ALK Mutation in Neuroblastoma on the point of Molecular Heterogeneity

Aktaş T. Ç., Kızmazoğlu D., Aktaş S., Gökbayrak Ö. E., Serinan E., Erol A., et al.

TECHNOLOGY IN CANCER RESEARCH AND TREATMENT , cilt.22, ss.1-7, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

31. DEVELOPMENT OF A NEW BIOMARKER AT THE LEVEL OF GENE CHANGE IN CISPLATIN OTOTOXICITY

KIZMAZOĞLU D., Erol A., Aktas T., OLGUN Y., Demir A., ALTUN Z. S., et al.

PEDIATRIC BLOOD & CANCER , cilt.70, 2023 (SCI-Expanded)

32. NIVOLUMAB EXPERIENCE IN REFRACTORY LYMPHOMA CASES WITH PD1, PDL1 POSITIVITY

Ince D., KIZMAZOĞLU D., ÇEÇEN R. E., Laleoglu P., Duran B., TÜFEKÇİ GÜROCAK Ö., et al.

PEDIATRIC BLOOD & CANCER , cilt.70, 2023 (SCI-Expanded)

33. Pathological and immunohistochemical findings of lungs, heart, liver, and kidneys, and unexpected findings of fungi and parasites in lungs of deceased COVID-19 patients: A case series

Yakar M. N., Ergun B., Erol A., Gokbayrak O., AKTAŞ T., Bagci O. U., et al.

JOURNAL OF ACUTE DISEASE , cilt.12, sa.5, ss.204-212, 2023 (ESCI)

34. Akciğer Kanseri ve Anjiotensin Dönüştürücü Enzim-2 İlişkisi

Ertuğrul A. V., Ömeroğlu Şimşek G., Aktaş T. Ç., Keskinkılıç M., Aktaş S.

İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi , cilt.1237501, ss.1-5, 2023 (Hakemli Dergi) Sürdürülebilir Kalkınma

35. Comparing Tribbles Homolog 3 (TRIB3) Protein Expression Levels with Clinicopathological Characteristics and Survival Among Neuroblastoma Patients

Baran B., Sanlav G., Kizmazoglu D., Ozsengezer S. K., Aktas S., Altun Z., et al.

CLINICAL MEDICINE INSIGHTS: ONCOLOGY , cilt.17, ss.1-8, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

36. Experimental Peritoneal Metastasis Model: Which type of rodents should we choose and which method should we perform for the intraperitoneal inoculation of tumor cells?

Manoğlu B., Bişgin T., Canda A. E., Aktaş S., Altun Z. S., Yılmaz O.

TURKISH JOURNAL OF COLORECTAL DISEASE , cilt.33, sa.3, ss.80-85, 2023 (Hakemli Dergi)

37. Nijmegen breakage syndrome in fraternal twins and synchronous development of nonhodgkin’s lymphoma

Kazancı E. G., Gülen H., Erbay A., Genel F., Aktaş S., Vergin C., et al.

Journal of Bursa Faculty of Medicine , cilt.1, sa.3, ss.94-98, 2023 (Hakemli Dergi)

38. Investigation of the effectiveness of hyperthermic intraperitoneal chemotherapy in experimental colorectal peritoneal metastasis model

MANOĞLU B., YAVUZŞEN T., AKTAŞ S., ALTUN Z. S., YILMAZ O., Gokbayrak O. E., et al.

PLEURA AND PERITONEUM , cilt.8, 2023 (ESCI, Scopus)

39. Unraveling the Mystery: Next Generation Sequencing Sheds Light on Neuroblastoma Pathogenesis and Targeted Therapies

Aktas T., Kizmazoglu D., Aktas S., Erol A., Serinan E., Gokbayrak O., et al.

FRONTIERS IN BIOSCIENCE-LANDMARK , cilt.28, sa.8, ss.171-180, 2023 (SCI-Expanded, Scopus)

40. Synthesis and Optimization of the Docetaxel-Loaded and Durvalumab-Targeted Human Serum Albumin Nanoparticles, In Vitro Characterization on Triple-Negative Breast Cancer Cells

Yurt Onaran F., Özel D., Tunçel A., Gökbayrak Ö., Aktaş S.

ACS OMEGA , cilt.3, sa.2682, ss.1-14, 2023 (SCI-Expanded)

41. Whole-exome sequencing reveals genetic variants in low-risk and high-risk neuroblastoma.

Altun Z. S., Yuan H., Baran B., Aktaş S., Esmeray Sönmez E., Küçük C., et al.

Gene , cilt.860, ss.147233, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

42. Noroblastomda Molekuler Heterojenite Ve Klinik Onemi - Molecular Heterogeneity In Neuroblastoma And Its Clinical Significance

Aktaş T. Ç., Aktaş S., Serinan E. Ö., Erçetin A. P., Aydın M., Gökbayrak Ö. E., et al.

Journal of Dr. Behcet Uz Children's Hospital , cilt.14238, ss.1-5, 2023 (ESCI)

43. Anna Karenina principle in personalized treatment of bladder cancer according to oncogram: which drug for which patient?

Celik S., Gokbayrak O., Erol A., Yorukoglu K., Aktas T., Sari H., et al.

Personalized medicine , cilt.20, ss.175-182, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

44. IMMUNE AND INFLAMATORYRESPONSE HETEROGENEITY IN NEUROBLASTOMA

Aktaş T. Ç., Kızmazoğlu D., Aktaş S., Serinan E. Ö., Çeçen R. E., İnce D., et al.

TURKISH JOURNAL OF BIOCHEMISTRY , cilt.47, sa.s1, ss.25, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

45. SUPEROXIDE DISMUTASE 2 PROTEIN LEVELS IN BLOOD MAY ACT AS A PROGNOSTIC MARKER FOR HIGH-RISK NEUROBLASTOMA PATIENTS

Demir A. B., ALTUN Z. S., AKTAŞ S., Olgun N.

JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES , cilt.7, sa.1, ss.196-213, 2023 (ESCI, TRDizin)

46. Effect of Colchicine on Secondary Acute Lung Injury in an Experimental Sepsis Model in Rats

Ceylan M., KÖSE Ş., Yilmaz H. O., AKTAŞ S., YILMAZ O.

MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS , cilt.12, 2023 (ESCI)

47. Molecular Heterogeneity in Neuroblastoma and Its Clinical Significance

Aktas T. C., AKTAŞ S., Serinan E. O., Aydin M., Gokbayrak O. E., Erol A., et al.

JOURNAL OF DR BEHCET UZ CHILDRENS HOSPITAL , cilt.13, sa.2, ss.123-129, 2023 (ESCI) Sürdürülebilir Kalkınma

48. **Identification of ALK Mutation in Neuroblastoma on the Point of Molecular Heterogeneity**

Aktas T. c., KIZMAZOĞLU D., AKTAŞ S., Gokbayrak O. E., Serinan E., Erol A., et al.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT , cilt.22, 2023 (SCI-Expanded, Scopus)

49. N-NITRO-L-ARGININE METHYL ESTER HYDROCHLORIDE INDUCED ENDOTHELIAL DYSFUNCTION AND ATHEROSCLEROSIS MODEL IN RATS

Simsek M. K., BARIŞ M. M., YILMAZ O., ALTUN Z. S., AKTAŞ S., ÇAKIR Y., et al.

JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES , cilt.7, sa.3, ss.114-121, 2023 (ESCI)

50. THE PROGNOSTIC ROLE OF EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION IN COMPLETELY RESECTED AMPULLARY ADENOCARCINOMA

Varol U., Cakir E., AKTAŞ S., ALTUN Z. S., Dilek F. H., Butun O., et al.

POLISH JOURNAL OF PATHOLOGY , cilt.74, sa.1, ss.18-28, 2023 (SCI-Expanded, Scopus)

51. Genomic Alterations of Signaling and DNA Damage Repair Pathways in Non-Muscle Invasive Bladder Cancer

Celik S., Aktas T., Gokbayrak O., Erol A., YÖRÜKOĞLU K., Yilmaz B., et al.

CANCER INVESTIGATION , cilt.41, sa.10, ss.848-857, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

52. Evaluation of MicroRNA Expressions in Ovarian Cancer

Yavuzsen H. T., ALTUN Z. S., Diniz G., Ayaz D., Sayhan S., Cakir I., et al.

EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY , cilt.6, sa.4, ss.299-306, 2022 (ESCI)

53. Dinutuximab beta plus conventional chemotherapy for relapsed/refractory high-risk neuroblastoma: A single-center experience

OLGUN H. N., ÇEÇEN R. E., İNCE D., KIZMAZOĞLU D., BAYSAL B., Onal A., et al.

Frontiers in Oncology , cilt.12, 2022 (SCI-Expanded, Scopus)

54. Protective role of Darbopoetin in Cisplatin-Induced Ototoxicity

Bayrak A. F., Olgun Y., Evin Eskicioğlu H., Kum Özşengezer S., Serinan E. Ö., Kolatan E. H., et al.

Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi , cilt.36, sa.3, ss.309-320, 2022 (Hakemli Dergi)

55. Protective Role Of Darbepoetin In Cisplatin-Induced Ototoxicity

Bayrak A. F., Olgun Y., Evin Eskicioğlu H., Kum Özşengezer S., Serinan E., Kolatan H. E., et al.

Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi , cilt.36, sa.3, ss.309-320, 2022 (Hakemli Dergi)

56. The Effect of Bevacizumab and Propranolol on Nasal Polyposis

Olgun Y., Aktaş S., Sütay S., Ecevit M. C.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , cilt.2022, ss.6174664, 2022 (SCI-Expanded)

57. Comparison of Cytotoxic and Ototoxic Effects of Lipoplatin and Cisplatin in Neuroblastoma In Vivo Tumor Model

EVİN ESKİCİOĞLU H., OLGUN Y., Aktas T. C., AKTAŞ S., KOLATAN H. E., Serinan E., et al.

JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY , cilt.18, sa.5, ss.392-398, 2022 (SCI-Expanded, Scopus)

58. Effect of Oleuropein on noise-induced hearing loss

Kümüş Ö., Olgun Y., Mungan Durankaya S., Aktaş S., Kırkım G., Sütay S.

JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY , cilt.18, ss.118-124, 2022 (SCI-Expanded)

59. Association of immune response with overall and disease-free survival in laryngeal squamous cell carcinomas

BAYRAK A. F., Eliyatkin N. O., Islek A., Ozkul Y., Kilic H. S., AKTAŞ S.

AMERICAN JOURNAL OF OTOLARYNGOLOGY , cilt.43, sa.4, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

60. Association of immune response with overall and disease-free survival in laryngeal squamous cell carcinomas

Bayrak F., Eliyatkın N. Ö., İşlek A., Özkul Y., Kılıç H. S., Aktaş S.

AMERICAN JOURNAL OF OTOLARYNGOLOGY - HEAD AND NECK MEDICINE AND SURGERY , cilt.43, sa.4, ss.103477-103478, 2022 (SCI-Expanded)

61. Expressions of MicroRNA of Mixed Cellularity Hodgkin Lymphomas are Different in Paediatric and Adult Patients

AKTAŞ S., Diniz G., Ceyhan M., Tosun-Yildirim H., Ceylan C., Oymak Y., et al.

WEST INDIAN MEDICAL JOURNAL , cilt.69, sa.8, ss.565-570, 2022 (SCI-Expanded)

62. EWSR1(22q12) Translocation Positive Pediatric Adrenal Tumor with Loss of 1p, 11q, and Unbalanced Gain of 17q: Neuroblastoma or Ewing Sarcoma?

AZİZOĞLU M., DEMİRSOY U., Kulac I., AKTAŞ S., Corapcioglu F.

FETAL AND PEDIATRIC PATHOLOGY , cilt.40, sa.6, ss.717-722, 2021 (SCI-Expanded)

63. Treatment of Relapse/Refractory Neuroblastoma: Dokuz Eylul University Experience

Cecen R. E., Ince D., Kizmazoglu D., Akyol S., Ozdogan O., Ozer E., et al.

PEDIATRIC BLOOD & CANCER , cilt.68, 2021 (SCI-Expanded)

64. Investigation of Molecular Sub-Groups by Immunohistochemical Methods and its Prognostic Importance in Medulloblastoma

Ataseven E., KANTAR M., AKTAŞ S., Erol A., Gokbayrak O., Ertan Y., et al.

PEDIATRIC BLOOD & CANCER , cilt.68, 2021 (SCI-Expanded)

65. Dinutuxumab Beta Plus Conventional Chemotherapy for Relapsed/Refractory High-Risk Neuroblastoma: A Single Centre Experience

OLGUN H. N., Cecen R. E., Ince D., Onal A., Baysal B., Akyol S., et al.

PEDIATRIC BLOOD & CANCER , cilt.68, 2021 (SCI-Expanded)

66. Assessment of ex-vivo efficacy of immunotherapeutic agents in intermediate-risk and high-risk non-muscle invasive bladder cancer

Celik S., Erol A., Gokbayrak O., SARI H., Yilmaz B., MUNGAN M. U., et al.

Journal of B.U.ON. , cilt.26, sa.6, ss.2577-2584, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

67. A candidate antineoplastic herbal agent for bladder cancer: Ankaferd Blood Stopper

SARI H., ÇELİK S., Caglar F., AKTAŞ S., BOZKURT O., YÖRÜKOĞLU K., et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , cilt.75, sa.11, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

68. Neuroblastoma-targeted Anticancer Drug Delivery

AKTAŞ S., GÖKBAYRAK Ö. E., EROL A., OLGUN H. N.

Journal of Dr. Behcet Uz Children s Hospital , cilt.11, sa.3, ss.29-225, 2021 (ESCI)

69. Promising Candidate As An Anticancer Agent For Childhood, A Sesquiterpene Lactone: Dehydroleucodine

EROL A., GÖKBAYRAK Ö. E., AKTAŞ S., OLGUN H. N.

International Journal For Research In Biology & Pharmacy , cilt.7, sa.8, ss.1-8, 2021 (Hakemli Dergi)

70. Colchicine limited secondary lung injury in an experimental rat sepsis model

Ceylan M., Yilmaz H. O., AKTAŞ S., YILMAZ O., Kose Ş.

EUROPEAN JOURNAL OF IMMUNOLOGY , cilt.51, ss.99, 2021 (SCI-Expanded)

71. Investigation of In-Vivo Effect of St. John’s Worth (Hypericum Perforatum) in Lung Cancer.

Aktaş S., Erol A., Serinan E., Gökbayrak Ö., Altun Z. S.

Journal of Veterinary Science and Medicine , cilt.9, sa.1, ss.1-4, 2021 (Hakemsiz Dergi) Sürdürülebilir Kalkınma

72. Evaluation of Liposomal and Microbubbles Mediated Delivery of Doxorubicin in Two-Dimensional (2D) and Three-Dimensional (3D) Models for Breast Cancer

Aydin M., Ozdemir E., Altun Z. S., Kilic S., Aktaş S.

EUROPEAN JOURNAL OF BREAST HEALTH , cilt.17, sa.3, ss.274-282, 2021 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

73. Effect of Korean Red Ginseng on Noise-Induced Hearing Loss

Mungan Durankaya S., Olgun Y., Aktaş S., Evin Eskicioğlu H., Gürkan S., Altun Z. S., et al.

TURKISH ARCHIVES OF OTORHINOLARYNGOLOGY , cilt.59, sa.2, ss.111-117, 2021 (ESCI)

74. Safety of Eicosapentaenoic Acid in Cancer Treatment: Effect on Cancer Cells and Chemotherapy in Vitro

Aktaş S., Ercetin P., Altun Z. S., Kantar M., Olgun N.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL , cilt.73, sa.4, ss.568-571, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

75. Investigation of In-Vivo Effect of St. John\u2019s Wort (Hypericum Perforatum) In Lung Cancer

AKTAŞ S., Erol A., Serinan E. Ö., Gökbayrak Ö. E., ALTUN Z. S.

Journal of Veterinary Science & Medicine , cilt.9, sa.1, ss.1-5, 2021 (Hakemli Dergi) Sürdürülebilir Kalkınma

76. The Effect of Ifosfamide and Mifamurtide Loaded Cement on The Viability of Osteosarcoma Cells

Bekçioğlu Ö., AKTAŞ S., AYDIN M., OLGUN H. N.

Turkish Journal of Hip Surgery , cilt.1, sa.3, ss.90-95, 2021 (Hakemli Dergi)

77. Questioning How to Define the "Ultra-High-Risk" Subgroup of Neuroblastoma Patients.

Demir A. B., Aktas S., Altun Z. S., Ercetin P., Aktas T. C., Olgun N.

Folia biologica , cilt.67, sa.1, ss.1-9, 2021 (SCI-Expanded, Scopus)

78. Evaluation of the Effect of Mesenchymal Stem Cells on Cisplatin Induced Toxicity in Neuroblastoma Tumor Model

AKTAŞ S., OLGUN Y., EVİN H., ERÇETİN A. P., Aktaş T., YILMAZ O., et al.

International Journal of Medical Science and Clinical Invention , cilt.8, sa.16, ss.5836-5848, 2021 (Hakemli Dergi)

79. Effect of Tacrolimus in Triple Negative Breast Cancer Animal Model

Aktaş S., Erçetin A. P., Kolatan H. E.

International Journal of Clinical and Experimental Medicine Research , cilt.5, sa.3, ss.269-277, 2021 (Hakemli Dergi)

80. Evaluating Molecular Heterogeneity in Neuroblastoma With Next Generation Sequencing (On behalf of Turkish Pediatric Oncology Group)

Aktas T., Yuan H., Gokbayrak O. E., Serinan E., Erol A., Aktas S., et al.

PEDIATRIC BLOOD & CANCER , cilt.67, 2020 (SCI-Expanded)

81. Evaluating ALK Mutations in Neuroblastoma With Next Generation Sequencing (On Behalf of Turkish Pediatric Oncology Group)

Aktas T., Yuan H., Gokbayrak O. E., Aktas S., Olgun N.

PEDIATRIC BLOOD & CANCER , cilt.67, 2020 (SCI-Expanded)

82. Determining the Effect of Retinoic Acid on PI3K/AKT and RAS/MAPK Pathways on Childhood Solid Tumors by using Western Blot

Gokbayrak O. E., Aktas S., Erol A., Altun Z. S., Olgun N.

PEDIATRIC BLOOD & CANCER , cilt.67, 2020 (SCI-Expanded)

83. Antioxidant effect of acetyl-l-carnitine against cisplatin-induced cardiotoxicity

Bayrak S., Aktaş S., Altun Z. S., Cakir Y., Tutuncu M., Ozsengezer S. K., et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , cilt.48, sa.8, 2020 (SCI-Expanded, Scopus)

84. Cadmium in bone cement induces necrosis and decreases the viability of residual osteosarcoma cells: A xenograft study

Demirkiran N. D., AKTAŞ S., Ozdemir A. P. E., Bekcioglu O., Aydin M., HAVITÇIOĞLU H.

ACTA ORTHOPAEDICA ET TRAUMATOLOGICA TURCICA , cilt.54, sa.4, ss.445-452, 2020 (SCI-Expanded)

85. Radiolabeling, In Vitro Cell Uptake, and In Vivo Photodynamic Therapy Potential of Targeted Mesoporous Silica Nanoparticles Containing Zinc Phthalocyanine

Er O., Tuncel A., Ocakoğlu K., Ince M., Kolatan H. E., Yılmaz O., et al.

MOLECULAR PHARMACEUTICS , cilt.17, sa.7, ss.2648-2659, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

86. The role of cancer stem cells in immunotherapy for bladder cancer: An in vitro study

Ozcan Y., Caglar F., ÇELİK S., Demir A. B., ERÇETİN A. P., Altun Z. S., et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS , cilt.38, sa.5, ss.476-487, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

87. Effect of Mesenchymal Stem Cells on Cochlear Cell Viability After Cisplatin Induced Ototoxicity

Erçetin A. P., Olgun Y., Aktaş S., Aydin M., Evin Eskicioğlu H., Altun Z. S., et al.

JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES , cilt.4, sa.3, ss.378-383, 2020 (ESCI)

88. Producing Longlasting Education Material For Oncology By Prolonged Tissue Processing: Preliminary Study

Tutuncu M., AKTAŞ S., DİNİZ ÜNLÜ A. G., ALTUN Z. S., OLGUN H. N.

The journal of Tepecik Education and Research Hospital , cilt.30, sa.1, ss.49-52, 2020 (Hakemli Dergi)

89. Evaluation of gene expression levels in the diagnosis of lung adenocarcinoma and malignant pleural mesothelioma

Ömeroğlu Şimşek G., Agababaoglu I., Dursun D., Ozekinci S., Ercetin P., Ellidokuz H., et al.

TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY , cilt.28, sa.1, ss.188-196, 2020 (SCI-Expanded, Scopus, TRDizin)

90. Assessment of ex-vivo efficacy (oncogram) of immunotherapeutic and chemotherapeutic agents in bladder cancer: A pilot study of personalized treatment

Celik S., Sari H., MUNGAN M. U., YÖRÜKOĞLU K., ÇELEBİ İ., AKTAŞ S.

JOURNAL OF BUON , cilt.25, sa.1, ss.295-301, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

91. Evaluation of Immunhistochemical ERG Tissue Expression in Wilms Tumor

Diniz G., Birol I. E., Oniz H., Vergin C., Aktas S.

IZMIR DR BEHCET UZ COCUK HASTANESI DERGISI , cilt.10, sa.1, ss.65-70, 2020 (ESCI)

92. In vitro Application of Cadmium within Bone Cement in Osteosarcoma

DEMİRKIRAN N. D., Ercetin P. A., Aydın M., Bekçioğlu Ö., HAVITÇIOĞLU H., AKTAŞ S.

Acta Oncologica Turcica , cilt.53, sa.1, ss.166-172, 2020 (Hakemli Dergi)

93. Xenograft Tumor Volume Measurement in Nude Mice: Estimation of 3D Ultrasound Volume Measurements Based on Manual Caliper Measurements

BARIŞ M. M., Serinan E., Calisir M., Simsek K., AKTAŞ S., YILMAZ O., et al.

JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES , cilt.4, sa.2, ss.90-95, 2020 (ESCI)

94. The efficacy of systemic and intravitreal infliximab treatments in an endotoxin-induced uveitis model

Donmez O., YAMAN A., ÖZTÜRK A. T., AKTAŞ S., ALTUN Z. S., YILMAZ O.

CUTANEOUS AND OCULAR TOXICOLOGY , cilt.38, sa.4, ss.360-369, 2019 (SCI-Expanded, Scopus)

95. Breast cancer risk in neurofibromatosis type 1 is a function of the type of NF1 gene mutation: a new genotype-phenotype correlation

Frayling I. M., Mautner V., van Minkelen R., Kallionpaa R. A., AKTAŞ S., Baralle D., et al.

JOURNAL OF MEDICAL GENETICS , cilt.56, sa.4, ss.209-219, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

96. Colorectal Cancer and Circulating Tumor DNA: Future Biomarker

Manoğlu B., ALTUN Z. S., YAVUZŞEN T., AKTAŞ S.

İzmir Tepecik Eğitim Hastanesi Dergisi , cilt.29, ss.11-20, 2019 (Hakemli Dergi) Sürdürülebilir Kalkınma

97. Childhood Malign Solid Soft Tissue Sarcomas; Diagnostic, Histopathological and Molecular Approach

Yildirim H. T., Yildirim A., Diniz G., AKTAŞ S., Vergin C.

IZMIR DR BEHCET UZ COCUK HASTANESI DERGISI , cilt.9, sa.1, ss.1-9, 2019 (ESCI)

98. MicroRNA-17, MicroRNA-19b, MicroRNA-146a, MicroRNA-302d Expressions in Hepatoblastoma and Clinical Importance

Ecevit C. O., Aktaş S., Yildirim H. T., Demirag B., Erbay A., Karaca I., et al.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , cilt.41, sa.1, ss.7-12, 2019 (SCI-Expanded)

99. Kolorektal kanser ve dolaşımdaki tümör DNA’sı: Geleceğin biyobelirteci. Colorectal Cancer and Circulating Tumor DNA: Future Biomarker.

Manoğlu B., ALTUN Z. S., YAVUZŞEN T., AKTAŞ S.

İzmir Tepecik Eğitim Hastanesi Dergisi , 2019 (Hakemli Dergi) Sürdürülebilir Kalkınma

100. Over kanserinde Mikro RNA’lar- MicroRNA’s in Ovarian Cancer

Yavuzşen H. T., Aktaş S., Saatli H. B., Altun Z. S.

Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi , cilt.33, sa.1, ss.2602-3148, 2019 (Hakemli Dergi) Sürdürülebilir Kalkınma

101. Scanning all chromosomal abnormalities with microarray-based comparative genomic hybridization in differential diagnosis of pediatric cancers

Yildirim H. T., Aktaş S., Diniz G., Aktas T. C., Baran B., Bayrak S., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY , cilt.12, sa.8, ss.3140-3148, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

102. Betulinic Acid and Cisplatin Inhibit Metastasis Related Genes in Neuroblastoma Cells Due to Their N-MYC Status

Bayrak S., Altun Z. S., İnce D., Aktaş S., Olgun N.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.29, sa.2, ss.70-78, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

103. Is Pool Water Disinfectant (Hydrogen Peroxide-Silver Composition) Ototoxic in Rats?

Demir E., Gulustan F., Atsal G., Dalgic A., Catli T., YILMAZ O., et al.

JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY , cilt.14, sa.3, ss.432-436, 2018 (SCI-Expanded)

104. Role of N-acetyl cysteine and acetyl-l-carnitine combination treatment on DNA-damage-related genes induced by radiation in HEI-OC1 cells

Duzenli U., Altun Z. S., OLGUN Y., AKTAŞ S., Pamukoglu A., ÇETİNAYAK H. O., et al.

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY , cilt.95, sa.3, ss.298-306, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma